(Press-News.org) (WASHINGTON, Oct. 19, 2023) – Patients with multiple myeloma treated with idecabtagene vicleucel, known as “ide-cel,” a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according to a study published in Blood Advances.
“With this study, we see that Black and white patients with multiple myeloma both respond well to ide-cel,” explained Laura Peres, PhD, an epidemiologist at Moffit Cancer Center and the study’s lead author. “We hope that these findings encourage the use of ide-cel in all patients with multiple myeloma.”
Multiple myeloma, a cancer of the plasma cells in the bone marrow, is the second most common blood cancer in the United States, with a five-year survival rate of 56%. Among Black and Hispanic populations, it is the most common blood cancer. While several treatments exist, the condition remains incurable, and most patients who achieve remission eventually relapse.
In CAR T-cell therapies, a patient’s T-cells are removed from their blood and a gene for a receptor that binds to a specific protein on cancer cells is added to help them find and destroy cancer cells. Then, the modified cells are infused back into the patient. In 2021, ide-cel became the first CAR T-cell therapy to gain approval from the U.S. Food and Drug Administration (FDA) to treat relapsed/refractory (RR) multiple myeloma, a version of the blood cancer that did not respond to treatment or that returned after treatment.
“Non-Hispanic Black individuals are twice as likely to develop multiple myeloma compared to their white counterparts,” emphasized Dr. Peres. “We also know that Black patients are less likely to receive these novel CAR-T therapies and are less represented in clinical trials. So, with this study, we wanted to look at how outcomes differ between racial and ethnic groups.”
To conduct this study, Dr. Peres and her research team collected data from 207 patients at 11 institutions that participated in the U.S. Multiple Myeloma Immunotherapy Consortium. 149 or 72% of patients identified as non-Hispanic white, 30, or 17% identified as non-Hispanic Black, while 22, or 11% identified as Hispanic. Patients with RR multiple myeloma received ide-cel and researchers monitored their remission rates, overall survival, and the prevalence of complications associated with CAR T-cells, following up with patients around nine months after treatment.
Dr. Peres’ findings suggest that non-Hispanic Black patients were more likely to develop cytokine release syndrome – a potentially dangerous side effect of the therapy that causes inflammation – than Hispanic and non-Hispanic white patients (97% vs 77% vs 85% respectively). However, the team did not find any significant differences in one’s likelihood of developing severe complications when comparing outcomes by race and ethnicity. Similarly, they found no significant differences in the incidence of intensive care unit admission, one’s likelihood of reaching complete remission, or overall survival between Black and white patients.
While the overall response rate – the percentage of patients that achieve a partial, very good partial, or complete response to CAR T – was lower among Hispanic patients compared to non-Hispanic Black and white patients, researchers suspect this could, in part, be attributed to the limited number of Hispanic patients included in the study.
Due to the FDA's approval of ide-cel in March 2021, this study had a limited sample size and follow-up duration. The study was retrospective, and race and ethnicity were self-reported. Conducted across 11 medical institutions, there might be variations in the assessment and management of CAR T-cell associated toxicities.
“These results highlight the need for diverse patient cohorts in research and clinical trials,” said Dr. Peres. “Clinical trials often lack diversity for many reasons such as recruitment barriers, financial considerations, medical mistrust, and cultural insensitivity. But stringent trial eligibility criteria also often exclude racial and ethnic minorities.
In fact, 75% of our study population would not have been eligible for the trial that led to FDA approval of ide-cel. A lack of clinical trial representation can limit underrepresented groups’ access to life-saving care.”
# # #
Blood Advances (www.bloodadvances.org) publishes more peer-reviewed hematology research than any other academic journal worldwide and is an online only, open access journal of the American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders.
Blood Advances® is a registered trademark of the American Society of Hematology.
Contact:
Kira Sampson, American Society of Hematology
ksampson@hematology.org; 202-499-1796
END
Biodiversity is essential for sustaining food security, livelihood, ecosystem health, and economic development and for preventing future epidemics. Asia, with nearly 60% of the world's population, stands out as a priority for urgent biodiversity conservation due to its large threatened species and protected areas (PAs), and many countries globally are facing extreme biodiversity and ecological threats. Satellite observations have shown that the human activities (i.e., cropland and artificial surface creations) in Asia have rapidly expanded since the 21st century and are being expanded to highlands (hilly and mountainous regions). Obviously, the intensification of human activities ...
Many people have experienced a muddy off-flavor in farmed fish. While the aquaculture industry has known about the problem for 20 years, it continues to impact the consumption of otherwise healthy and potentially sustainable fish. Now, University of Copenhagen researchers have been able to pinpoint exactly when the off-flavors emerge. And this can make it easier to deal with the compounds that turn people away from farmed fish.
Yuk! Musty, earthy or muddy-tasting fish is never going to go over well with the family. Perhaps you’ve tasted it in trout caught from a put-and-take pond. The off-flavor ...
Highlights:
High blood pressure affects a large share of the global adult population.
Previous studies suggest probiotics may help prevent hypertension.
New findings point to 2 additional probiotics as potential treatments.
Blood pressure in hypertensive mice returned to healthy levels after treatment with Bifidobacterium lactis and Lactobacillus rhamnosus.
The researchers also identified relationships between unexplored gut microbes and hypertension.
Washington, D.C. – An estimated 40% of the global adult population have high blood pressure, or hypertension, ...
As a combustible fuel, the burning of hydrogen gas does not contribute to global warming. Today, the majority of hydrogen gas is generated from fossil fuels, however, and this process releases greenhouse gasses into the atmosphere. Generating hydrogen gas from clean sources, such as the splitting of water molecules with electricity through electrolysis, is important to achieving future carbon neutrality, but current methods are inefficient and limit the commercial practicality of hydrogen-based technologies. ...
HOUSTON – (Oct. 19, 2023) – Rice University scientists used a commercially available mixed-reality headset with custom-designed software to measure and analyze forest floor vegetation, demonstrating a correlation between animal diversity and the mapped habitat of a Tanzanian national park. According to the paper published in the journal Ecology, the greater the microhabitat surface area, the richer the biodiversity of its mammals.
Traditional habitat field research requires a significant amount of time and effort, but Rice postdoctoral researcher Daniel Gorczynski reduced those costs by ...
SCOTTSDALE, Ariz. — Oct. 18, 2023 — In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might one day help doctors detect pancreatic cancer earlier.
The team from the U.S., China, South Korea and Japan created and tested a biomarker panel that detects small amounts of RNA genetic material that breaks off from pancreatic cancer cells and circulates in the bloodstream, known ...
Scientists and natural resource managers from Canadian First Nations, governments, academic institutions, and conservation organizations published the first results of a unique salmon population monitoring tool in Frontiers in Marine Science. This groundbreaking new technology, dubbed “Salmon Vision,” combines artificial intelligence with age-old fishing weir technology. Early assessments show it to be remarkably adept at identifying and counting fish species, potentially enabling real-time salmon population monitoring for fisheries managers.
“In ...
Unemployment among the youth is a serious problem in many developing countries, especially in Africa. This issue stems in great part from a stagnant manufacturing sector. Firms in African countries have failed to grow significantly over the past decade, leading to fewer job positions for the youth.
Foreign direct investment (FDI) is a promising avenue for addressing this challenge. Local firms in developing countries can learn advanced technologies and management strategies from multinational companies. This transmission of knowledge, in general, helps make ...
G protein-coupled receptors (GPCRs) are the largest and most diverse group of cell surface proteins in humans. These receptors, which can be seen as ‘traffic directors,’ transmit signals from the outside to the inside of cells and are involved in many physiological processes. Given their prominent roles in cellular communication, cell growth, immune responses, and sensory perception, many drugs have been developed to target GPCRs, for the treatment of conditions such as asthma, allergies, depression, hypertension, and heart disease. In fact, more than 300 GPCR-related drugs are currently in clinical trials, 36% ...
Proteins are important molecules that perform a variety of functions essential to life. To function properly, many proteins must fold into specific structures. However, the way proteins fold into specific structures is still largely unknown. Researchers from the University of Tokyo developed a novel physical theory that can accurately predict how proteins fold. Their model can predict things previous models cannot. Improved knowledge of protein folding could offer huge benefits to medical research, as well as to various industrial processes.
You are literally made of proteins. These chainlike molecules, made from tens to thousands of smaller molecules called amino acids, form things like hair, ...
